Glycogen Storage Disease Type IV: Clinical Trials

4 trials for Glycogen Storage Disease Type IV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown, 1 withdrawn. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 21Completed 1

Follow Glycogen Storage Disease Type IV: new trials by email Literature Review of Glycogen Storage Disease Type IV trials Research Report on Glycogen Storage Disease Type IV

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biomarker for Glycogen Storage Diseases (BioGlycogen)
Fructose Metabolism, Inborn Errors, Glycogen Storage Disease
WithdrawnCENTOGENE GmbH Rostock2018-08-202023-02-13
Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy
Sugar - Metabolism, Inborn Errors, Lipid Metabolism, Inborn Errors
Not applicableUnknownCopenhagen University Hospital, Rigshospitalet602016-01-012019-10-16
GBE Deficiency (GSD IV and APBD) Natural History Study
No intervention - Glycogen Storage Disease Type IV, Adult Polyglucosan Body Disease
RecruitingDuke University2002015-12-012026-05-05
Triheptanoin Treatment Trial for Patients With Adult Polyglucosan Body Disease
Triheptanoin, Vegetable Oil - Adult Polyglucosan Body Disease, Glycogen Brancher Enzyme Deficiency
Phase 2CompletedBaylor Research Institute232009-06-012018-03-05

Narrower conditions

Glycogen Storage Disease Type II (2)  ·  Glycogen Storage Disease Type III (2)  ·  Glycogen Storage Disease Type V (2)  ·  Glycogen Storage Disease Type VII (2)  ·  Polyglucosan Body Disease, Adult Form (2)  ·  Carbohydrate Metabolism, Inborn Errors (1)  ·  Carnitine palmitoyl transferase 2 deficiency (1)  ·  Chanarin-Dorfman Syndrome (1)  ·  Dimauro disease (1)  ·  Fructose Metabolism, Inborn Errors (1)  ·  Glycogen Storage Disease (1)  ·  Glycogen Storage Disease Type I (1)  ·  Glycogen Storage Disease Type Ix (1)  ·  Glycogen Storage Disease Type VI (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Genetic Diseases, Inborn (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Carbohydrate Metabolism, Inborn Errors (3)  ·  Glycogen Storage Disease (3)  ·  Metabolic Diseases (3)  ·  Metabolism, Inborn Errors (3)  ·  Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Central Nervous System Diseases (2)  ·  Lysosomal Storage Diseases, Nervous System (2)  ·  Muscular Diseases (2)  ·  Muscular Disorders, Atrophic (2)  ·  Muscular Dystrophies (2)

Interventions

Plant Oils (1)  ·  Sugars (1)  ·  triheptanoin (1)

Sponsors

Baylor Research Institute (1)  ·  CENTOGENE GmbH Rostock (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Duke University (1)

Countries

Denmark (1)  ·  France (1)  ·  Germany (1)  ·  India (1)  ·  Sri Lanka (1)  ·  United States (1)

Top investigators

Karen L Madsen, MD (1)  ·  Peter Bauer, Prof. (1)  ·  Priya Kishnani, MD (1)  ·  Raphael Schiffmann, M.D, M.H.Sc (1)

Results publications

PMID 29110179, PMID 30990523, PMID 31492716, PMID 38912588